Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 19, 2008

Primary Completion Date

December 22, 2008

Study Completion Date

December 22, 2008

Conditions

Schizophrenia

Interventions

DRUG

GSK1018921

GSK1018921 is a GT1 recepor antagonist

Trial Locations (1)

GSK Investigational Site, Barcelona